Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease

NeuroImage

Volumn 113, Issue , 2015, Pages 61-69

  Vemuri, Prashanthi ^a   Senjem, Matthew L ^a,b   Gunter, Jeffrey L ^a,b   Lundt, Emily S ^c   Tosakulwong, Nirubol ^c   Weigand, Stephen D ^c   Borowski, Bret J ^a   Bernstein, Matt A ^a   Zuk, Samantha M ^a   Lowe, Val J ^a   Knopman, David S ^d   Petersen, Ronald C ^d   Fox, Nick C ^e   Thompson, Paul M ^f,h   Weiner, Michael W ^g,i   Jack, Clifford R ^a  

^a Departments of Radiology   (United States)

^b Information Technology   (United States)

^c Health Sciences Research   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SYMMETRIC DIFFEOMORPHIC IMAGE NORMALIZATION; TENSOR BASED MORPHOMETRY; ALGORITHM; ARTIFICIAL INTELLIGENCE; BRAIN MAPPING; COGNITIVE DEFECT; DIFFUSION TENSOR IMAGING; INFORMATION PROCESSING; MIDDLE AGED; NEUROIMAGING; PATHOLOGY; PROCEDURES; PSYCHOLOGY; QUALITY CONTROL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; ALZHEIMER DISEASE; ARTIFICIAL INTELLIGENCE; BRAIN MAPPING; COGNITIVE DYSFUNCTION; DATASETS AS TOPIC; DIFFUSION TENSOR IMAGING; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEUROIMAGING; QUALITY CONTROL;

EID: 84925871316     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.03.026     Document Type: Article

References (43)

1. Acion L., Peterson J.J., Temple S., Arndt S. Probabilistic index: an intuitive non-parametric approach to measuring the size of treatment effects. Stat. Med. 2006, 25:591-602.
2. Avants B.B., Epstein C.L., Grossman M., Gee J.C. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med. Image Anal. 2008, 12:26-41.
3. Blaimer M., Breuer F., Mueller M., Heidemann R.M., Griswold M.A., Jakob P.M. SMASH, SENSE, PILS, GRAPPA: how to choose the optimal method. Top. Magn. Reson. Imaging 2004, 15:223-236.
4. Boyes R.G., Gunter J.L., Frost C., Janke A.L., Yeatman T., Hill D.L., Bernstein M.A., Thompson P.M., Weiner M.W., Schuff N., Alexander G.E., Killiany R.J., DeCarli C., Jack C.R., Fox N.C. Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. NeuroImage 2008, 39:1752-1762.
5. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 1997, 18:351-357.
6. Ching C.R.K., Hua X., Hibar D.P., Ward C.P., Gunter J.L., Bernstein M.A., Jack C.R., Weiner M., Thompson P.M. Does MRI scan acceleration affect power to track brain change?. Neurobiol. Aging 2015 Jan, 36(Suppl 1):S167-S177.
7. Cover K.S., van Schijndel R.A., van Dijk B.W., Redolfi A., Knol D.L., Frisoni G.B., Barkhof F., Vrenken H. Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans. Psychiatry Res. 2011, 193:182-190.
8. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
9. Fleisher A.S., Donohue M., Chen K., Brewer J.B., Aisen P.S. Applications of neuroimaging to disease-modification trials in Alzheimer's disease. Behav. Neurol. 2009, 21:129-136.
10. Fox N.C., Scahill R.I., Crum W.R., Rossor M.N. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 1999, 52:1687-1689.
11. Fox N.C., Ridgway G.R., Schott J.M. Algorithms, atrophy and Alzheimer's disease: cautionary tales for clinical trials. NeuroImage 2011, 57:15-18.
12. Freeborough P.A., Fox N.C. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans. Med. Imaging 1997, 16:623-629.
13. Frisoni G.B., Fox N.C., Jack C.R., Scheltens P., Thompson P.M. The clinical use of structural MRI in Alzheimer disease. Nat. Rev. Neurol. 2010, 6:67-77.
14. Frisoni G.B., Bocchetta M., Chetelat G., Rabinovici G.D., de Leon M.J., Kaye J., Reiman E.M., Scheltens P., Barkhof F., Black S.E., Brooks D.J., Carrillo M.C., Fox N.C., Herholz K., Nordberg A., Jack C.R., Jagust W.J., Johnson K.A., Rowe C.C., Sperling R.A., Thies W., Wahlund L.O., Weiner M.W., Pasqualetti P., Decarli C. Imaging markers for Alzheimer disease: which vs how. Neurology 2013, 81:487-500.
15. Griswold M.A., Jakob P.M., Nittka M., Goldfarb J.W., Haase A. Partially parallel imaging with localized sensitivities (PILS). Magn. Reson. Med. 2000, 44:602-609.
16. Griswold M.A., Jakob P.M., Heidemann R.M., Nittka M., Jellus V., Wang J., Kiefer B., Haase A. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn. Reson. Med. 2002, 47:1202-1210.
17. Gunter J.L., Shiung M.M., Manduca A., Jack C.R. Methodological considerations for measuring rates of brain atrophy. J. Magn. Reson. Imaging 2003, 18:16-24.
18. Gunter J.L., Bernstein M.A., Borowski B.J., Ward C.P., Britson P.J., Felmlee J.P., Schuff N., Weiner M., Jack C.R. Measurement of MRI scanner performance with the ADNI phantom. Med. Phys. 2009, 36:2193-2205.
19. Holland D., McEvoy L.K., Dale A.M. Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI. Hum. Brain Mapp. 2012, 33:2586-2602.
20. Hua X., Leow A.D., Parikshak N., Lee S., Chiang M.C., Toga A.W., Jack C.R., Weiner M.W., Thompson P.M. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676AD, MCI, and normal subjects. NeuroImage 2008, 43:458-469.
21. Hua X., Hibar D.P., Ching C.R., Boyle C.P., Rajagopalan P., Gutman B.A., Leow A.D., Toga A.W., Jack C.R., Harvey D., Weiner M.W., Thompson P.M. Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. NeuroImage 2013, 66:648-661.
22. Jack C.R., Bernstein M.A., Fox N.C., Thompson P., Alexander G., Harvey D., Borowski B., Britson P.J., J, L.W., Ward C., Dale A.M., Felmlee J.P., Gunter J.L., Hill D.L., Killiany R., Schuff N., Fox-Bosetti S., Lin C., Studholme C., DeCarli C.S., Krueger G., Ward H.A., Metzger G.J., Scott K.T., Mallozzi R., Blezek D., Levy J., Debbins J.P., Fleisher A.S., Albert M., Green R., Bartzokis G., Glover G., Mugler J., Weiner M.W. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J. Magn. Reson. Imaging 2008, 27:685-691.
23. Jack C.R., Bernstein M.A., Borowski B.J., Gunter J.L., Fox N.C., Thompson P.M., Schuff N., Krueger G., Killiany R.J., Decarli C.S., Dale A.M., Carmichael O.W., Tosun D., Weiner M.W. Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement. 2010, 6:212-220.
24. Jack C.R., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S., Shaw L.M., Vemuri P., Wiste H.J., Weigand S.D., Lesnick T., Pankratz V.S., Donohue M., Trojanowski J.Q. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013, 12:207-216.
25. Klein A., Andersson J., Ardekani B.A., Ashburner J., Avants B., Chiang M.C., Christensen G.E., Collins D.L., Gee J., Hellier P., Song J.H., Jenkinson M., Lepage C., Rueckert D., Thompson P., Vercauteren T., Woods R.P., Mann J.J., Parsey R.V. Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. NeuroImage 2009, 46:786-802.
26. Krueger G., Granziera C., Jack C.R., Gunter J.L., Littmann A., Mortamet B., Kannengiesser S., Sorensen A.G., Ward C.P., Reyes D.A., Britson P.J., Fischer H., Bernstein M.A. Effects of MRI scan acceleration on brain volume measurement consistency. J. Magn. Reson. Imaging 2012, 36:1234-1240.
27. Kruggel F., Turner J., Muftuler L.T. Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort. NeuroImage 2010, 49:2123-2133.
28. Leow A.D., Yanovsky I., Parikshak N., Hua X., Lee S., Toga A.W., Jack C.R., Bernstein M.A., Britson P.J., Gunter J.L., Ward C.P., Borowski B., Shaw L.M., Trojanowski J.Q., Fleisher A.S., Harvey D., Kornak J., Schuff N., Alexander G.E., Weiner M.W., Thompson P.M. Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. NeuroImage 2009, 45:645-655.
29. Leung K.K., Barnes J., Ridgway G.R., Bartlett J.W., Clarkson M.J., Macdonald K., Schuff N., Fox N.C., Ourselin S. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. NeuroImage 2010, 51:1345-1359.
30. Leung K.K., Clarkson M.J., Bartlett J.W., Clegg S., Jack C.R., Weiner M.W., Fox N.C., Ourselin S. Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection. NeuroImage 2010, 50:516-523.
31. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
32. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morric J.C., Rosser M.N., Scheltens P., Thies W., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Assocation Workgroup. Alzheimers Dement. 2011, 7:263-269.
33. Mormino E.C., Kluth J.T., Madison C.M., Rabinovici G.D., Baker S.L., Miller B.L., Koeppe R.A., Mathis C.A., Weiner M.W., Jagust W.J. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 2009, 132:1310-1323.
34. Newcombe R.G. Confidence intervals for an effect size measure based on the Mann-Whitney statistic. Part 2: asymptotic methods and evaluation. Stat. Med. 2006, 25:559-573.
35. Pruessmann K.P., Weiger M., Scheidegger M.B., Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn. Reson. Med. 1999, 42:952-962.
36. Risacher S.L., Shen L., West J.D., Kim S., McDonald B.C., Beckett L.A., Harvey D.J., Jack C.R., Weiner M.W., Saykin A.J. Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol. Aging 2010, 31:1401-1418.
37. Rosner B. Fundamentals of Biostatistics 2011, Brooks/Cole, Cengage Learning, Boston.
38. Savva G.M., Wharton S.B., Ince P.G., Forster G., Matthews F.E., Brayne C. Age, neuropathology, and dementia. N. Engl. J. Med. 2009, 360:2302-2309.
39. Schott J.M., Bartlett J.W., Barnes J., Leung K.K., Ourselin S., Fox N.C. Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiol. Aging 2010, 31:1452-1462. (1462 e1451-1452).
40. Sodickson D.K., Manning W.J. Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn. Reson. Med. 1997, 38:591-603.
41. Thompson W.K., Holland D. Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates. NeuroImage 2011, 57:1-4.
42. Vemuri P., Gunter J.L., Senjem M.L., Whitwell J.L., Kantarci K., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. NeuroImage 2008, 39:1186-1197.
43. Vemuri P., Wiste H.J., Weigand S.D., Knopman D.S., Trojanowski J.Q., Shaw L.M., Bernstein M.A., Aisen P.S., Weiner M., Petersen R.C., Jack C.R., Initiative A.S.D.N. Serial MRI and CSF biomarkers in normal aging, MCI and AD. Neurology 2010, 75:143-151.